MSB 2.23% $1.10 mesoblast limited

GvHD v CHF

  1. 1,363 Posts.
    lightbulb Created with Sketch. 116

    Jeez there is a lot of crap written on here.


    LVAD pilot trial

     - 2/3 of the trial population were Ischemic

     - Weaning end point was successful

    - went on to a 2b trial larger population


    LVAD 2B Trial

     - 1/3 of the trial population were Ischemic

     - In this 1/3 weaning was successful


    Guess what????? the majority of the patients in the CHF trial are Ischemic.  So the LVAD results are actually a big positive for CHF phase 3 trial.


    Doubters....just go away now please


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.10
Change
-0.025(2.23%)
Mkt cap ! $1.250B
Open High Low Value Volume
$1.13 $1.16 $1.04 $14.57M 13.49M

Buyers (Bids)

No. Vol. Price($)
4 21024 $1.09
 

Sellers (Offers)

Price($) Vol. No.
$1.10 241 1
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.